Value-Based Pricing of US Prescription Drugs: Estimated Savings Using Reports From the Institute for Clinical and Economic Review

This cross-sectional study estimates how annual US drug spending would change if prices for prescription drugs were set at the value-based price.

Detalles Bibliográficos
Autores principales: Yeung, Kai, Bloudek, Lisa, Ding, Yao, Sullivan, Sean D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856524/
https://www.ncbi.nlm.nih.gov/pubmed/36484998
http://dx.doi.org/10.1001/jamahealthforum.2022.4631
_version_ 1784873652187037696
author Yeung, Kai
Bloudek, Lisa
Ding, Yao
Sullivan, Sean D.
author_facet Yeung, Kai
Bloudek, Lisa
Ding, Yao
Sullivan, Sean D.
author_sort Yeung, Kai
collection PubMed
description This cross-sectional study estimates how annual US drug spending would change if prices for prescription drugs were set at the value-based price.
format Online
Article
Text
id pubmed-9856524
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-98565242023-02-03 Value-Based Pricing of US Prescription Drugs: Estimated Savings Using Reports From the Institute for Clinical and Economic Review Yeung, Kai Bloudek, Lisa Ding, Yao Sullivan, Sean D. JAMA Health Forum Research Letter This cross-sectional study estimates how annual US drug spending would change if prices for prescription drugs were set at the value-based price. American Medical Association 2022-12-09 /pmc/articles/PMC9856524/ /pubmed/36484998 http://dx.doi.org/10.1001/jamahealthforum.2022.4631 Text en Copyright 2022 Yeung K et al. JAMA Health Forum. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Yeung, Kai
Bloudek, Lisa
Ding, Yao
Sullivan, Sean D.
Value-Based Pricing of US Prescription Drugs: Estimated Savings Using Reports From the Institute for Clinical and Economic Review
title Value-Based Pricing of US Prescription Drugs: Estimated Savings Using Reports From the Institute for Clinical and Economic Review
title_full Value-Based Pricing of US Prescription Drugs: Estimated Savings Using Reports From the Institute for Clinical and Economic Review
title_fullStr Value-Based Pricing of US Prescription Drugs: Estimated Savings Using Reports From the Institute for Clinical and Economic Review
title_full_unstemmed Value-Based Pricing of US Prescription Drugs: Estimated Savings Using Reports From the Institute for Clinical and Economic Review
title_short Value-Based Pricing of US Prescription Drugs: Estimated Savings Using Reports From the Institute for Clinical and Economic Review
title_sort value-based pricing of us prescription drugs: estimated savings using reports from the institute for clinical and economic review
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856524/
https://www.ncbi.nlm.nih.gov/pubmed/36484998
http://dx.doi.org/10.1001/jamahealthforum.2022.4631
work_keys_str_mv AT yeungkai valuebasedpricingofusprescriptiondrugsestimatedsavingsusingreportsfromtheinstituteforclinicalandeconomicreview
AT bloudeklisa valuebasedpricingofusprescriptiondrugsestimatedsavingsusingreportsfromtheinstituteforclinicalandeconomicreview
AT dingyao valuebasedpricingofusprescriptiondrugsestimatedsavingsusingreportsfromtheinstituteforclinicalandeconomicreview
AT sullivanseand valuebasedpricingofusprescriptiondrugsestimatedsavingsusingreportsfromtheinstituteforclinicalandeconomicreview

Ejemplares similares